Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Mucocutaneous Leishmaniasis With Miltefosine

NCT01050907 is registered in ClinicalTrials.gov with Knight Therapeutics (USA) Inc as lead sponsor.

NCT NCT01050907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01050907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Mucocutaneous Leishmaniasis With Miltefosine
Lead sponsor
Knight Therapeutics (USA) Inc
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2010
Completion date
March 31, 2015
Enrollment
4 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous leishmaniasis, mucosal leishmaniasis